The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
Cancer Treatment Reviews · 2023-02 · 113 · 102500
DOI: 10.1016/j.ctrv.2022.102500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-02. Verfasst von Claudia von Arx und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: claudia.vonarx@ist…. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Immunoconjugates. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: claudia.vonarx@istitutotumori.na.it.
- Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
- Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy.
- Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy.
Zitieren
APA
von Arx, C., De Placido, P., Caltavituro, A., Di Rienzo, R., Buonaiuto, R., De Laurentiis, M., Arpino, G., Puglisi, F., Giuliano, M., & Del Mastro, L. (2023). The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Reviews, 113, 102500. https://doi.org/10.1016/j.ctrv.2022.102500
Vancouver
von Arx C, De Placido P, Caltavituro A, Di Rienzo R, Buonaiuto R, De Laurentiis M, et al. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Reviews. 2023;113:102500. doi:10.1016/j.ctrv.2022.102500
BibTeX
@article{vonArx2023,
author = {von Arx, Claudia and De Placido, Pietro and Caltavituro, Aldo and Di Rienzo, Rossana and Buonaiuto, Roberto and De Laurentiis, Michelino and Arpino, Grazia and Puglisi, Fabio and Giuliano, Mario and Del Mastro, Lucia},
title = {The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer},
journal = {Cancer Treatment Reviews},
year = {2023},
volume = {113},
pages = {102500},
doi = {10.1016/j.ctrv.2022.102500}
}
EUVIMED